E-mail: ddvorak@volny.cz
Odborné práce publikované na Linkos.cz
Přehled odborných textů publikovaných autorem na portálu Linkos.cz. Jsou zde uvedeny knihy a brožury, články v Klinické onkologii, tuzemská abstrakta z databáze abstrakt a další texty. Rejstřík není v žádném případě úplným autorským rejstříkem, protože jsou zde uvedeny pouze texty zveřejněné na portálu Linkos.cz.
Publikované knihy
Publikovaná abstrakta
- A NOVEL MGB PROBE-BASED ASSESSMENT OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA CARRYING NPM1 (NUCLEOPHOSMIN) EXON 12 MUTATIONS
- ACUTE MYELOID LEUKEMIAS WITH RECURRENT GENETIC ABNORMALITIES: FREQUENT ASSESSMENT OF MINIMAL RESIDUAL DISEASE AND TREATMENT OF MOLECULAR RELAPSE
- ACHIEVEMENT OF BCL-2/IGH NEGATIVITY IN PERIPHERAL BLOOD/BONE MARROW IS ASSOCIATED WITH BETTER CLINICAL OUTCOME IN PATIENTS WITH FOLLICULAR LYMPHOMA
- AN ATYPICAL JUNCTION OF BCR-ABL GENE AS MOLECULAR MARKER FOR QUANTITATIVE MONITORING OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML)
- Analýza genové exprese u folikulárního lymfomu pomocí oligonukleotidových microarrays
- ARE MUTATIONS IN THE IDH2 GENE SUITABLE MOLECULAR MARKERS FOR MRD MONITORING IN AML PATIENTS?
- AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: STILL NOT OUT OF FASHION
- BONE MARROW VERSUS PERIPHERAL BLOOD: COMPARISON OF THE CHIMERISM ANALYSIS
- BONE MARROW/PERIPHERAL BLOOD POSITIVITY OF BCL-2/IGH REARRANGEMENT IN PATIENTS WITH FOLLICULAR LYMPHOMA BEFORE TREATMENT HAS NO PROGNOSTIC SIGNIFICANCE
- CD26 ANTIGEN IS SPECIFIC FOR LEUKEMIC STEM CELLS IN CHRONIC MYELOID LEUKEMIA AND DISTINGUISHES PATIENT GROUPS WITH DIFFERENT RATIOS OF LEUKEMIC AND HEALTHY STEM CELL
- CEBPA GENE MUTATIONAL STATUS: A COMPLETE SCREENING USING HIGH-RESOLUTION MELT CURVE ANALYSIS
- CLOFARABINE IN THE TREATMENT OF ACUTE MYELOID LEUKEMIA – SINGLE CENTER EXPERIENCE
- CO VLASTNĚ VÍME O PŘESTAVBĚ GENU ALK U NSCLC?
- COMPLETE HEMATOLOGIC REMISSION BUT NOT MOLECULAR REMISSION IS ASSOCIATED WITH PROLONGED SURVIVAL IN PATIENTS WITH ACUTE LEUKEMIA BEFORE HEMATOPOIETIC STEM CELL TRANSPLANTATION
- Consolidation Therapy Based on Conventional Chemotherapy and Corticoids Do Not Provide Therapeutic Advantage for Newly Diagnosed Patients after Autologous Transplantation.
- Constitutive Activation of STAT1 and STAT3 Proteins on Serine and Tyrosine Residues Were Found in Majority of CLL
- CONSTITUTIVE ACTIVATION OF STAT1 AND STAT3 PROTEINS WITHOUT INTERFERON INDUCIBILITY: RELEVANCE TO THERAPY IN IGVH-UNMUTATED CLL PATIENTS
- CRISOTINIB V LÉČBĚ POKROČILÉHO NEMALOBUNĚČNÉHO KARCINOMU PLIC
- Cytogenetic Aberration Profile of Chronic Myeloid Leukemia and Its Dynamic Changes During Imatinib Therapy
- DASATINIB EFFICACY AND TOLERANCE IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA (CML) PATIENTS RESISTANT/INTOLERANT TO IMATINIB IN THE CONTEXT OF REAL CLINICAL PRACTICE MANAGEMENT
- DEFINITION AND VALIDATION OF NOVEL PROGNOSTIC MARKERS IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
- Detection and Treatment of Molecular Relapse in Acute Myeloid Leukemia with RUNX1, CBFB or MLL Gene Translocations. Frequent Quantitative Monitoring of Molecular Markers in Different Compartments and Correlation with WT1 Gene Expression.
- DETECTION OF AN ABERRANT FORM OF E13A2 BCR-ABL TRANSCRIPT CAUSING FAILURE OF MOLECULAR DIAGNOSTICS IN PATIENT WITH CHRONIC MYELOID LEUKEMIA (CML)
- Detection of Molecular Relapse of AML by Very Frequent Quantitative Monitoring of Different Molecular Markers (Fusion Transcripts and WT1) in Different Compartments (Peripheral Blood-PB, Bone Marrow-BM, and Selected CD34+ Bone Marrow Cells) and Its..
- DETECTION OF MOLECULAR RELAPSE OF AML BY VERY FREQUENT QUANTITATIVE MONITORING OF DIFFERENT MOLECULAR MARKERS IN DIFFERENT COMPARTMENTS AND ITS TREATMENT WITH CHEMOTHERAPY OR GEMTUZUMAB OZOGAMICIN
- Detekce herpetických virů u imunokompromitovaných pacientů metodou „real-time“ PCR
- DETEKCE PŘESTAVBY EML4/ALK METODOU RT-PCR U PACIENTŮ S NEMALOBUNĚČNÝM KARCINOMEM PLIC (NSCLC)
- Diagnostika genu EML4-ALK a jeho prediktivní význam u nemalobuněčného karcinomu plic (NSCLC)
- DYNAMICS OF LINEAGE-SPECIFIC CHIMERISM IN PATIENTS AFTER NON-MYELOABLATIVE HEMATOPOIETIC STEM CELL TRANSPLANTATION
- EFFICACY AND SAFETY OF IMATINIB IN THE FIRST LINE CHRONIC MYELOID LEUKEMIA (CML) TREATMENT. AN ANALYSIS OF A COMPREHENSIVE POPULATION-BASED DATABASE
- GAIN/AMPLIFICATION OF 1Q21 IS THE MOST POWERFUL GENETIC PROGNOSTIC FACTOR FOR PATIENTS TREATED BY AUTOLOGOUS STEM CELL TRANSPLANTATION
- HIGH RESOLUTION CYTOGENETIC MAPPING AND WHOLE EXOME SEQUENCING REVEAL A COMPLEX PATTERN OF CHROMOSOME 6P ABERRATIONS IN PATIENTS WITH MYELOID MALIGNANCIES
- CHARACTERIZATION OF P53 AND ATM ABNORMALITIES IN B-CLL PATIENTS
- Chimerism Status as a Possible Marker of Incipient Disease Relapse in Patients with AML.
- CHRONIC MYELOID LEUKEMIA: IS THE REAL PROGNOSIS OF NEWLY DIAGNOSED PATIENTS REALLY SO GOOD?
- IMATINIB IN THE FIRST LINE CHRONIC MYELOID LEUKEMIA (CML) TREATMENT. CAN WE COMPARE THE REAL-LIFE DATA TO CLINICAL TRIAL RESULTS?
- IMATINIB IN THE FIRST-LINE CML TREATMENT: AN ANALYSIS OF A COMPREHENSIVE NON-COMMERCIAL DATABASE OF ALL CONSECUTIVE PATIENTS IN A DEFINED POPULATION
- IMPACT OF TREATMENT ADMINISTRATION ON SELECTION OF BCRABL1 KINASE DOMAIN MUTATIONS
- INFUSION OF HLA-MISMATCHED PERIPHERAL BLOOD STEM CELLS DURING TREATMENT AML IN ELDERLY PATIENTS
- IS NONMYELOABLATIVE TRANSPLANT SUFFICIENT TO CURE CHRONIC MYELOID LEUKEMIA?
- Izolace RNA pro účely RT-PCR, Real-Time PCR a DNA čipů z tkání fixovaných ve formalínu a archivovaných v parafinových bločcích
- LONG-TERM RESULTS OF REDUCED-INTENSITY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR 1ST CHRONIC PHASE CML
- MICROCHIMERISM – LOOK INTO THE INCIPIENT AML RELAPSE?
- Minimal Residual Resistance In CML: Stable BCR-ABL Gene Expression at Levels 0.01–0.1% (IS) In the Consecutive Samples May Be Associated with BCR-ABL Mutation Development and MMoR Lost In a Small Number of Tyrosine Kinase Inhibitor Responders
- MOLECULAR ANALYSIS OF IGVH GENE MUTATIONAL STATUS AS A PROGNOSTIC FACTOR IN B – CLL WITHIN CZECH PATIENTS
- MOLECULAR CYTOGENETIC STUDY OF IMMUNOFLUORESCENTLY LABELED PLASMA CELLS AND PROGNOSTIC SIGNIFICANCE OF CLONAL CHROMOSOMAL ABERRATIONS IN 208 PATIENS WITH MULTIPLE MYELOMA
- Monitoring of Minimal Residual Disease in NPM1 Mutated Acute Myeloid Leukemia (AML) – a Single Center Experience in 27 Patients
- MONITORING OF MRD BY NPM1 MUTATIONS FROM MRNA AND GENOMIC DNA AND ITS COMPARISON WITH EXPRESSION OF WT1 GENE IN AML PATIENTS
- MONITORING OF THE STATUS OF BOTH P53 ALLELES IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA - RELEVANCE TO PROGNOSIS AND TREATMENT
- Mutační analýza genu EGFR u pacientů s nemalobuněčným karcinomem plic (NSCLC) ve FN Brno.
- NEUROMUSCULAR TOXICITY OF TYROSINE KINASE INHIBITORS IN THE THERAPY OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA
- Optimalizace kombinovaných režimů CVD (Cyklofosfamid, Velcade, Dexametazon) v České republice: pilotní analýza režimů CVD junior a CVD senior s nižším dávkováním u nemocných s relabujícím mnohočetným myelomem
- OPTIMIZATION OF BORTEZOMIB-BASED COMBINATIVE REGIMEN IN ELDERLY RELAPSED MULTIPLE MYELOMA PATIENTS
- PARALELNÍ VÝSKYT DVOU TYPŮ MUTACÍ GENU EGFR - KAZUISTIKA DVOU PACIENTŮ S NEMALOBUNĚČNÝM KARCINOMEM PLIC (NSCLC)
- PERSISTENCE OF LYMPH NODE T(14;18) BEARING CELLS IN FOLLICULAR LYMPHOMA PATIENTS IN CLINICAL COMPLETE REMISSION: PROOF OF PRINCIPLE FOR MAINTENANCE THERAPY?
- PERSISTENT MICROCHIMERISM IN BONE MARROW: INFLUENCE OF MESENCHYMAL STEM CELLS
- PREDICTION OF IMATINIB THERAPY RESPONSE: A ROLE OF INTRACELLULAR TRANSPORTERS HOCT-1 AND ABCB1
- Profilování genové exprese u lymfoidních malignit: Validace vybraných molekulární markerů u difúzního velkobuněčného B-lymfocytárního lymfomu (DLBCL)
- PROGNOSTIC SIGNIFICANCE OF GENETIC ABERRATIONS IN SECONDARY ACUTE MYELOID LEUKEMIA
- Prognostický význam mutačního stavu genu TP53 u pacientů s B-buněčnou chronickou lymfocytární leukémií – význam monitorováni obou alel.
- QUANTITATIVE DETECTION OF MINIMAL RESIDUAL DISEASE IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA USING LNA-MODIFIED TAQ-MAN PROBES AND IGH-RQ PCR
- SKIN ADVERSE EFFECTS OF TYROSINE KINASE INHIBITORS IN THE THERAPY OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA – SINGLE CENTRE EXPERIENCE
- Sledování defektů ve fosforylaci STAT1, STAT3 proteinů a jejich význam pro stanovení prognózy u CLL pacientů
- Sledování exprese vybraných genů u pacientů s B-buněčnou chronickou lymfocytární leukémií – záchyt změny leukemického klonu vlivem terapie
- T(14;18) IN FOLLICULAR LYMPHOMA: A REAL- TIME (PCR) FOR A REAL LIFE….?
- T315I MUTATIONS ARE CLUSTERED WITH ADVANCED PHASES CONTRARY TO OTHER ABERRATIONS IN CML PATIENTS RESISTANT TO TKI THERAPY
- The Plateau of BCR-ABL Transcript Level =;>0.1% May Select CML Patients in Complete Cytogenetic Remission for Mutation Analysis.
- THE POOR PROGNOSIS ASSOCIATED WITH GAIN/AMPLIFICATION OF 1Q21 IN RELAPSED MULTIPLE MYELOMA PATIENTS MAY BE OVERCOME BY VELCADE BASED REGIMEN IN CONTRARY OF THALIDOMIDE BASED REGIMEN
- THE PROSPECTIVE ANALYSIS OF LOW LEVEL BCR-ABL1 T315I MUTATION IN THE CD34+ CELLS OF DE NOVO CML PATIENTS
- The Reduced Intensity Cvd Regimen: A Good Option with Well Balanced Efficacy/Toxicity Ratio for Elderly Patients with Poor Status Performance
- TREATMENT OF MOLECULAR RELAPSE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
- TREATMENT OF MOLECULAR RELAPSE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
- UNEXPECTED ANTAGONISTIC EFFECT OF RITUXIMAB WITH PROCARBAZINE DISCLOSED DURING AN IN VITRO TESTING OF RITUXIMAB-MEDIATED SENSITIZATION OF B-CELL LINES TO COMMONLY USED ANTICANCER DRUGS
- Úskalí molekulární diagnostiky Ewingova sarkomu / PNET
- Využití long-oligonucleotide arrayCGH v diagnostice leukémií.
- Využití RNA interference při regulaci genové exprese antionkogenu p53
- Využití RNA interference při regulaci genové exprese antionkogenu p53
- ZÁCHYT ATYPICKÉ PŘESTAVBY GENU ALK U PACIENTA S NEMALOBUNĚČNÝM KARCINOMEM PLIC (NSCLC)
Články v Klinické onkologii
- Autologní transplantace s podáním interleukinem 2 aktivovaného štěpu periferních kmenových buněk nemocným s chronickou myeloidní leukemií
- Molekulárně biologická diagnostika mutací genu KRAS a BRAF u pacientů s kolorektálním karcinomem – zkušenosti laboratorního pracoviště
- Molekulárně genetické vyšetření u akutní myeloidní leukemie
- Nové léky v terapii akutní myeloidní leukemie u starších pacientů
